^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Unituxin (dinutuximab)

    i
    Other names: Ch14.18, Ch 14.18UTC, MOAB Ch14.18, OP-08
    Company:
    Ohara Pharma, United Therapeutics Corp
    Drug class:
    GD2 ganglioside inhibitor
    Related drugs: